Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

Summary

The aim of this trial is to investigate the efficacy and tolerance of Ambroxol lozenges 20 mg in the treatment of sore throat in patients with acute viral pharyngitis.

Timeline

Start

2007-08-01

Primary completion

2008-01-01

Completion

2008-01-01

Outcome

Met primary endpoint

registry analysis (other test); Ambroxol Lozenges 20 mg vs Placebo; p = 0.0156; Mean Difference (Final Values) -0.07 (95% CI -0.12 to -0.01); ANOVA NCT00525044 ↗

Drugs

Indications